Transplant Brands

Bausch Health's branded azathioprine tablet (75 mg and 100 mg strengths), distributed by Salix Pharmaceuticals (a division of Bausch Health US, LLC) and manufactured by Alcami Corporation, indicated for renal transplant rejection prevention and severe rheumatoid arthritis, based on the immunosuppressant azathioprine originally developed by Nobel laureate Gertrude Elion at Burroughs Wellcome in the 1950s.

Prescription immunosuppressant medication (mycophenolate mofetil) for preventing organ rejection in transplant recipients, originally developed by Syntex Laboratories and now marketed by Roche.